Target intelligence / Profile preview

Sweet taste receptor (TAS1R2-TAS1R3 heterodimer) (TAS1R2-TAS1R3)

Target
TAS1R2-TAS1R3
Molecular classification
G protein-coupled receptor, Class C GPCR, Receptor
01

Overview

The **sweet taste receptor** is a heterodimer composed of two subunits, **TAS1R2** and **TAS1R3**, both members of the class C G protein-coupled receptor (GPCR) family[2][3][1][5][6]. The obligate heterodimer is localized to taste cells in the tongue and is responsible for sensing a wide range of sweet compounds, including natural sugars, artificial sweeteners, and sweet-tasting proteins[2][3][1][6]. Each subunit contains a Venus flytrap domain, a cysteine-rich domain, and a seven-transmembrane domain; the functional receptor requires both subunits, with sweet ligand binding occurring primarily at the Venus flytrap domain of TAS1R2[2][3][7][1][5]. Activation of the receptor leads to GPCR-mediated intracellular signaling via gustducin and other pathways, driving the perception of sweetness[4][2]. Beyond taste, it may also participate in metabolic regulation, linking dietary choices to metabolic health. Although it is not a classic drug target, the sweet taste receptor is significant for food science, obesity research, and potentially for the design of new therapeutics or nutritional interventions targeting metabolic diseases via modulation of taste and sugar perception[2][3].

Other names
Sweet taste receptor heterodimerType 1 taste receptor heterodimerTAS1R2-TAS1R3 receptorT1R2-T1R3 receptor
02

Mechanism of action

Agonism (activation of the receptor by binding to the Venus flytrap domain, primarily on TAS1R2, leading to conformational changes and initiating downstream GPCR signaling)[2][3][7][1]. Allosteric modulation (proposed binding sites for various modulators influencing receptor activity)[1]

03

Biological functions

Signal transductionSweet taste perceptionMetabolic regulation
04

Disease associations

Metabolic diseasesObesity (via dietary preferences and sugar intake)Other (indirect implication by influencing eating behaviors)
05

Safety considerations

Off-target effects of artificial sweeteners or novel sweetener drug candidates (potential for metabolic dysregulation or unclear long-term consequences of receptor modulation)Difficulty in selective targeting due to structural similarities with other class C GPCRs
06

Interacting drugs

Artificial sweeteners (e.g., sucralose, aspartame, neotame)

2 more in the full profile.

07

Biomarkers

null (currently no widely established clinical biomarkers for this specific receptor’s function or dysregulation)

Beyond the preview

Go deeper on Sweet taste receptor (TAS1R2-TAS1R3 heterodimer) (TAS1R2-TAS1R3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sweet taste receptor (TAS1R2-TAS1R3 heterodimer) (TAS1R2-TAS1R3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call